Wikidata entity: Q244408
C₁₄H₁₁Cl₂NO₂ (P274)
Quantities
| P2067 | mass | 295.017 |
| P4896 | 3D model | CommonsMedia | http://commons.wikimedia.org/wiki/Special:FilePath/Diclofenac-from-xtal-3D-bs-17.png | ??? |
| P3780 | active ingredient in | ... | Q47521309 (Cambia) | Cambia |
| P3780 | active ingredient in | ... | Q47521479 (Voltaren) | Voltaren |
| P3780 | active ingredient in | ... | Q47521480 (Pennsaid) | Pennsaid |
| P3780 | active ingredient in | ... | Q47521521 (Dyloject) | Dyloject |
| P3780 | active ingredient in | ... | Q47521615 (Flector) | Flector |
| P3780 | active ingredient in | ... | Q47522134 (Solaraze) | Solaraze |
| P3780 | active ingredient in | ... | Q47522359 (Zorvolex) | Zorvolex |
| P3780 | active ingredient in | ... | Q48828078 (Zipsor) | Zipsor |
| P233 | canonical SMILES | String | C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl | ??? |
| P373 | Commons category | String | Diclofenac | ??? |
| P1552 | has characteristic | ... | Q1517187 (bitterness) | bitterness |
| P527 | has part(s) | ... | Q627 (nitrogen) | nitrogen |
| P527 | has part(s) | ... | Q629 (oxygen) | oxygen |
| P527 | has part(s) | ... | Q623 (carbon) | carbon |
| P527 | has part(s) | ... | Q688 (chlorine) | chlorine |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P3493 | legal status (medicine) | ... | Q879952 (boxed warning) | boxed warning |
| P8026 | LiverTox likelihood score | ... | Q83283320 (LiverTox toxicity likelihood category A) | LiverTox toxicity likelihood category A |
| P1987 | MCN code | String | 2922.49.64 | ??? |
| P2175 | medical condition treated | ... | Q81938 (pain) | pain |
| P2175 | medical condition treated | ... | Q101991 (inflammation) | inflammation |
| P2175 | medical condition treated | ... | Q133087 (gout) | gout |
| P2175 | medical condition treated | ... | Q133823 (migraine) | migraine |
| P2175 | medical condition treated | ... | Q187255 (rheumatoid arthritis) | rheumatoid arthritis |
| P2175 | medical condition treated | ... | Q52851 (plantar fasciitis) | plantar fasciitis |
| P2175 | medical condition treated | ... | Q170990 (arthritis) | arthritis |
| P2175 | medical condition treated | ... | Q62736 (osteoarthritis) | osteoarthritis |
| P2175 | medical condition treated | ... | Q281289 (photophobia) | photophobia |
| P2175 | medical condition treated | ... | Q422225 (actinic keratosis) | actinic keratosis |
| P2175 | medical condition treated | ... | Q708176 (arthropathy) | arthropathy |
| P2175 | medical condition treated | ... | Q52849 (ankylosing spondylitis) | ankylosing spondylitis |
| P2175 | medical condition treated | ... | Q55781316 (osteoarthritis susceptibility 1) | osteoarthritis susceptibility 1 |
| P2175 | medical condition treated | ... | Q3518022 (rotator cuff tear) | rotator cuff tear |
| P2175 | medical condition treated | ... | Q3667186 (keratosis) | keratosis |
| P2175 | medical condition treated | ... | Q540571 (fibromyalgia) | fibromyalgia |
| P2175 | medical condition treated | ... | Q861224 (juvenile rheumatoid arthritis) | juvenile rheumatoid arthritis |
| P2175 | medical condition treated | ... | Q3724157 (migraine without aura) | migraine without aura |
| P2175 | medical condition treated | ... | Q945238 (peripheral neuropathy) | peripheral neuropathy |
| P2175 | medical condition treated | ... | Q2457358 (medial epicondylitis) | medial epicondylitis |
| P129 | physically interacts with | ... | Q415364 (Prostaglandin-endoperoxide synthase 2) | Prostaglandin-endoperoxide synthase 2 |
| P129 | physically interacts with | ... | Q21102111 (Acid sensing ion channel subunit 3) | Acid sensing ion channel subunit 3 |
| P129 | physically interacts with | ... | Q21126810 (Prostaglandin-endoperoxide synthase 1) | Prostaglandin-endoperoxide synthase 1 |
| P129 | physically interacts with | ... | Q1084878 (Peroxisome proliferator activated receptor gamma) | Peroxisome proliferator activated receptor gamma |
| P3489 | pregnancy category | ... | Q28123617 (US pregnancy category C) | US pregnancy category C |
| P3489 | pregnancy category | ... | Q3679261 (Australian pregnancy category C) | Australian pregnancy category C |
| P769 | significant drug interaction | ... | Q186969 (ibuprofen) | ibuprofen |
| P769 | significant drug interaction | ... | Q367700 (cyclosporine) | cyclosporine |
| P769 | significant drug interaction | ... | Q388801 (furosemide) | furosemide |
| P769 | significant drug interaction | ... | Q58396 (imipramine) | imipramine |
| P769 | significant drug interaction | ... | Q58397 (amitriptyline) | amitriptyline |
| P769 | significant drug interaction | ... | Q155472 (valsartan) | valsartan |
| P769 | significant drug interaction | ... | Q58713 (clomipramine) | clomipramine |
| P769 | significant drug interaction | ... | Q18216 (aspirin) | aspirin |
| P769 | significant drug interaction | ... | Q190016 (heparin) | heparin |
| P769 | significant drug interaction | ... | Q409192 ((RS)-ketoprofen) | (RS)-ketoprofen |
| P769 | significant drug interaction | ... | Q409236 (fluvoxamine) | fluvoxamine |
| P769 | significant drug interaction | ... | Q409672 ((RS)-citalopram) | (RS)-citalopram |
| P769 | significant drug interaction | ... | Q410074 (losartan) | losartan |
| P769 | significant drug interaction | ... | Q410237 (clopidogrel) | clopidogrel |
| P769 | significant drug interaction | ... | Q411648 (tacrolimus) | tacrolimus |
| P769 | significant drug interaction | ... | Q411932 ((S)-duloxetine) | (S)-duloxetine |
| P769 | significant drug interaction | ... | Q412050 (prostacyclin) | prostacyclin |
| P769 | significant drug interaction | ... | Q407617 (sertraline) | sertraline |
| P769 | significant drug interaction | ... | Q408471 (paroxetine) | paroxetine |
| P769 | significant drug interaction | ... | Q421119 (captopril) | captopril |
| P769 | significant drug interaction | ... | Q421156 (olmesartan) | olmesartan |
| P769 | significant drug interaction | ... | Q422185 (enalapril) | enalapril |
| P769 | significant drug interaction | ... | Q422188 (spironolactone) | spironolactone |
| P769 | significant drug interaction | ... | Q422212 (budesonide) | budesonide |
| P769 | significant drug interaction | ... | Q422244 (fluoxetine) | fluoxetine |
| P769 | significant drug interaction | ... | Q422252 (dexamethasone) | dexamethasone |
| P769 | significant drug interaction | ... | Q221520 (triamterene) | triamterene |
| P769 | significant drug interaction | ... | Q275926 (bumetanide) | bumetanide |
| P769 | significant drug interaction | ... | Q277785 (perindopril) | perindopril |
| P769 | significant drug interaction | ... | Q422232 (methotrexate) | methotrexate |
| P769 | significant drug interaction | ... | Q412666 (ramipril) | ramipril |
| P769 | significant drug interaction | ... | Q414028 (meloxicam) | meloxicam |
| P769 | significant drug interaction | ... | Q408676 (piroxicam) | piroxicam |
| P769 | significant drug interaction | ... | Q408801 (celecoxib) | celecoxib |
| P769 | significant drug interaction | ... | Q423804 (eplerenone) | eplerenone |
| P769 | significant drug interaction | ... | Q423930 (hydrochlorothiazide) | hydrochlorothiazide |
| P769 | significant drug interaction | ... | Q424972 (prednisone) | prednisone |
| P769 | significant drug interaction | ... | Q596022 (quinapril) | quinapril |
| P769 | significant drug interaction | ... | Q733186 (telmisartan) | telmisartan |
| P769 | significant drug interaction | ... | Q784717 (eprosartan) | eprosartan |
| P769 | significant drug interaction | ... | Q45050 (tenoxicam) | tenoxicam |
| P769 | significant drug interaction | ... | Q47495698 (lisinopril dihydrate) | lisinopril dihydrate |
| P769 | significant drug interaction | ... | Q105969996 (enoxaparin) | enoxaparin |
| P769 | significant drug interaction | ... | Q304088 (acenocoumarol) | acenocoumarol |
| P769 | significant drug interaction | ... | Q307088 (abciximab) | abciximab |
| P769 | significant drug interaction | ... | Q347941 (parecoxib) | parecoxib |
| P769 | significant drug interaction | ... | Q425207 (nabumetone) | nabumetone |
| P769 | significant drug interaction | ... | Q425289 (chlorthalidone) | chlorthalidone |
| P769 | significant drug interaction | ... | Q113368879 (rac-warfarin) | rac-warfarin |
| P769 | significant drug interaction | ... | Q3563148 (vortioxetine) | vortioxetine |
| P769 | significant drug interaction | ... | Q3655338 (cangrelor) | cangrelor |
| P769 | significant drug interaction | ... | Q481757 (aceclofenac) | aceclofenac |
| P769 | significant drug interaction | ... | Q898407 (venlafaxine) | venlafaxine |
| P769 | significant drug interaction | ... | Q414462 (apixaban) | apixaban |
| P769 | significant drug interaction | ... | Q415220 (pemetrexed) | pemetrexed |
| P769 | significant drug interaction | ... | Q5135114 ((2RS,6RS)-clopamide) | (2RS,6RS)-clopamide |
| P769 | significant drug interaction | ... | Q11426176 (prednisolone) | prednisolone |
| P769 | significant drug interaction | ... | Q20817139 (iloprost) | iloprost |
| P769 | significant drug interaction | ... | Q929420 (trandolapril) | trandolapril |
| P769 | significant drug interaction | ... | Q415366 (tirofiban) | tirofiban |
| P769 | significant drug interaction | ... | Q415970 (candesartan) | candesartan |
| P769 | significant drug interaction | ... | Q416132 (betamethasone) | betamethasone |
| P769 | significant drug interaction | ... | Q20817252 (tinzaparin) | tinzaparin |
| P769 | significant drug interaction | ... | Q27074832 (azilsartan) | azilsartan |
| P769 | significant drug interaction | ... | Q27077698 (fondaparinux) | fondaparinux |
| P769 | significant drug interaction | ... | Q27132753 (tenofovir disoproxil) | tenofovir disoproxil |
| P769 | significant drug interaction | ... | Q416232 (prasugrel) | prasugrel |
| P769 | significant drug interaction | ... | Q417222 (methylprednisolone) | methylprednisolone |
| P769 | significant drug interaction | ... | Q419890 ((±)-flurbiprofen) | (±)-flurbiprofen |
| P769 | significant drug interaction | ... | Q947266 (irbesartan) | irbesartan |
| P769 | significant drug interaction | ... | Q963093 (sulindac) | sulindac |
| P769 | significant drug interaction | ... | Q1078392 (indapamide) | indapamide |
| P769 | significant drug interaction | ... | Q419995 (amiloride) | amiloride |
| P769 | significant drug interaction | ... | Q420262 (rivaroxaban) | rivaroxaban |
| P769 | significant drug interaction | ... | Q420542 (ticagrelor) | ticagrelor |
| P769 | significant drug interaction | ... | Q1169164 ((RS)-bendroflumethiazide) | (RS)-bendroflumethiazide |
| P769 | significant drug interaction | ... | Q1215575 (naproxen) | naproxen |
| P769 | significant drug interaction | ... | Q1640947 (phenindione) | phenindione |
| P769 | significant drug interaction | ... | Q1851701 (dalteparin) | dalteparin |
| P769 | significant drug interaction | ... | Q2295855 (eptifibatide) | eptifibatide |
| P769 | significant drug interaction | ... | Q2465218 ((RS)-etodolac) | (RS)-etodolac |
| P769 | significant drug interaction | ... | Q2555245 ((RS)-fenoprofen) | (RS)-fenoprofen |
| P279 | subclass of | ... | Q11173 (chemical compound) | chemical compound |
| P2868 | subject has role | ... | Q188724 (non-steroidal anti-inflammatory drug) | non-steroidal anti-inflammatory drug |
| P2868 | subject has role | ... | Q20522059 (cyclooxygenase inhibitors) | cyclooxygenase inhibitors |
| P2868 | subject has role | ... | Q1747785 (non-opioid analgesic) | non-opioid analgesic |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | diclofenac | ??? |
Why not click here or view trends?
log id: 1671015